[Form 4] Lumentum Holdings Inc. Insider Trading Activity

Rhea-AI Filing Summary

Julia Suzanne Johnson, a director of Lumentum Holdings Inc. (LITE), reported a sale of 1,250 shares of the issuer's common stock on 08/18/2025 at a per-share price of $119.0622. After the transaction she beneficially owned 22,037 shares directly. The Form 4 was signed on behalf of the reporting person by an attorney-in-fact, Jae Kim, on 08/20/2025.

Insights

Financial Analyst

TL;DR: Director sale disclosed; transaction size is modest relative to typical institutional trades and appears routine.

The Form 4 shows a single non-derivative sale of 1,250 shares at $119.0622, leaving the director with 22,037 shares. This disclosure provides clear, timely transparency about insider liquidity. The absolute dollar value (~$148,828) is relatively small for most corporates and does not, by itself, indicate material change to company ownership or control.

Corporate Governance Expert

TL;DR: Filing meets Section 16 reporting requirements; signature via attorney-in-fact is properly noted.

The Form 4 is complete for the reported non-derivative sale and notes attorney-in-fact authentication. The report documents compliance with reporting timelines and specifies direct ownership after the sale. No amendments or additional transactions are disclosed.

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Johnson Julia Suzanne

(Last) (First) (Middle)

C/O LUMENTUM HOLDINGS INC.,

1001 RIDDER PARK DRIVE

(Street)

SAN JOSE CA 95131

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
Lumentum Holdings Inc. [ LITE ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

3. Date of Earliest Transaction (Month/Day/Year)
08/18/2025

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	08/18/2025		S		1,250	D	$119.0622	22,037	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

	/s/ Jae Kim as Attorney-in-Fact	08/20/2025
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What insider transaction did LITE director Julia Suzanne Johnson report?

She reported a sale of 1,250 shares of Lumentum common stock on 08/18/2025 at $119.0622 per share.

How many LITE shares does Julia Suzanne Johnson own after the reported sale?

Following the transaction she beneficially owned 22,037 shares directly.

When was the Form 4 for the LITE transaction signed and by whom?

The Form 4 was signed on behalf of the reporting person by attorney-in-fact Jae Kim on 08/20/2025.

What was the per-share price for the LITE sale reported on Form 4?

The reported sale price was $119.0622 per share.

Does the Form 4 report any derivative transactions for Lumentum (LITE)?

No. Table II for derivative securities contains no reported transactions in this filing.